The shares of Ventas, Inc. (NYSE:VTR) has been pegged with a rating of Equal-Weight by Morgan Stanley in its latest research note that was published on March 28th, 2019. The research company has also assigned a $61 price target. Morgan Stanley wasn’t the only research firm that published a report of Ventas, Inc., with other equities research analysts also giving their opinion on the stock. RBC Capital Mkts advised investors in its research note published on November 2nd, 2018, to Sector Perform the VTR stock. The stock had earned Neutral rating from JP Morgan when it published its report on October 30th, 2018. That day the JP Morgan set price target on the stock to $60. The stock was given Underperform rating by Evercore ISI in its report released on May 21st, 2018. Hilliard Lyons was of a view that VTR is Long-term Buy in its latest report on April 27th, 2018. Evercore ISI thinks that VTR is worth In-line rating. This was contained in the firm’s report on January 30th, 2018.

Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 15 believe it has the potential for further growth, thus rating it as Hold while 0 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $61.21. The price of the stock the last time has raised by 28.37% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 32.27.

The shares of the company dipped by -3.78% during the trading session on Tuesday, reaching a low of $59.51 while ending the day at $59.75. During the trading session, a total of 2.67 million shares were traded which represents a -32.88% decline from the average session volume which is 2.01M shares. VTR had ended its last session trading at 62.10. Ventas, Inc. currently has a market cap of $21.29B, while its P/E ratio stands at 63.09, while its P/E earnings growth sits at 5.68, with a beta of 0.38. Ventas, Inc. debt-to-equity ratio currently stands at 1.03, while its quick ratio hovers at . VTR 52-week low price stands at $46.55 while its 52-week high price is $65.70.

The Ventas, Inc. generated $923.26 million in revenue during the last quarter, which is slightly higher than the $918.34 million predicted by analysts. Ventas, Inc. has the potential to record 0.95 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Pivotal Research Group published a research note on April 3rd, 2019 where it informed investors and clients that Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is now rated as Hold. Their price target on the stock stands at $60. RBC Capital Mkts also rated WBA as Downgrade on November 2nd, 2018, with its price target of $67 suggesting that WBA could surge by 18.9% from its current share price. Even though the stock has been trading at $54.24/share, analysts expect it to surge higher by 1.11% to reach $67.62/share. It started the day trading at $54.96 and traded between $53.97 and $54.84 throughout the trading session.

A look at its technical shows that WBA’s 50-day SMA is 63.80 while its 200-day SMA stands at 70.26. The stock has a high of $86.31 for the year while the low is $53.32. The company’s P/E ratio currently sits at 10.96, while the P/B ratio is 2.06. At the moment, only of Walgreens Boots Alliance, Inc. shares were sold short. The company’s average trading volume currently stands at 6.87M shares, which means that the short-interest ratio is just 3.70 days. Over the past seven days, the company moved, with its shift of 0.62%. Looking further, the stock has dropped -23.61% over the past 90 days while it lost -25.39% over the last six months.

The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more WBA shares, increasing its portfolio by +1.35% during the last quarter. This move now sees The Vanguard Group Inc purchasing 936,719 shares in the last quarter, thus it now holds 70,334,070 shares of WBA, with a total valuation of $4,450,036,609. SSgA Funds Management Inc meanwhile sold more WBA shares in the recently filed quarter, changing its stake to $2,754,033,769 worth of shares. BlackRock Fund Advisors followed the path by increasing its WBA portfolio by +3.70% in the quarter. This means that BlackRock Fund Advisors bought 1,266,330 shares in the last quarter and now controls 35,515,374 shares of the WBA stock, with the valuation hitting $2,247,057,713.

Similarly, Capital Research Management Co increased its Walgreens Boots Alliance, Inc. shares by +5.27% during the recently filed quarter. After buying 608,172 shares in the last quarter, the firm now controls 12,153,347 shares of Walgreens Boots Alliance, Inc. which are valued at $768,942,265. In the same vein, Northern Trust Investments Inc increased its Walgreens Boots Alliance, Inc. shares by during the most recent reported quarter. The firm bought 641,721 shares during the quarter which increased its stakes to 11,641,152 shares and is now valued at $736,535,687. Following these latest developments, around 0.20% of Walgreens Boots Alliance, Inc. stocks are owned by institutional investors and hedge funds.